Aura Biosciences (AURA) Capital Expenditures (2020 - 2026)
Aura Biosciences (AURA) reported Capital Expenditures of $21,000 for Q2 2026, down 46.2% from $39,000 a year earlier and down 79.4% from the prior quarter.
Powered by 
Analysis
Aura Biosciences (AURA) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Aura Biosciences' Capital Expenditures came in at $344,000, down 60.3% year-over-year; for FY2025, it was $447,000, down 64.3% from FY2024.
- Capital Expenditures has a five-year compound annual growth rate of -10.3% (FY2020 to FY2025).
- By year, Capital Expenditures came in at $1.25 million in FY2024 (+76.7%), $709,000 in FY2023 (-35.2%), $1.09 million in FY2022 (-48.5%) and $2.13 million in FY2021 (+175.6%).
- The Q2 2026 figure ranks as the lowest quarterly Capital Expenditures in data going back to Q4 2020.
- Year over year, Capital Expenditures has now declined in each of the last five quarters, with growth averaging 9.2% over the last eight quarters.
- The high point for year-over-year Capital Expenditures in five years was Q1 2022 (growth of 743.7%); the low point was Q2 2025 (a decline of 92.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $102,000 (Q1 2026), $176,000 (Q4 2025) and $45,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Aura Biosciences | 796.17 Mn | 542.36 Mn | - | 80,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 80,000.00 |
| Jun 30, 2026 | 21,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 45,000.00 |
| Jun 30, 2025 | 39,000.00 |
| Mar 31, 2025 | 187,000.00 |
| Dec 31, 2024 | 299,000.00 |
| Sep 30, 2024 | 341,000.00 |
| Jun 30, 2024 | 525,000.00 |
| Mar 31, 2024 | 88,000.00 |
| Dec 31, 2023 | 317,000.00 |
| Sep 30, 2023 | 90,000.00 |
| Jun 30, 2023 | 193,000.00 |
| Mar 31, 2023 | 109,000.00 |
| Dec 31, 2022 | 358,000.00 |
| Sep 30, 2022 | 63,000.00 |
| Jun 30, 2022 | 74,000.00 |
| Mar 31, 2022 | 599,000.00 |
| Dec 31, 2021 | 819,000.00 |
API Access
Aura Biosciences Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "AURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=AURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();